2Billion dollar company without lung cancer phase 2
again new math with new quotes
5000eu22 patients x 100000 500mio. 10% 50mio.
15000screens x 1500$ 22,5mio numbers who come in 72,5mio x10 only eu 725mio the same for us but we take 50% from merck thats 270mio = 342,5mio revenue in the next 3years plus Tubulysin plus lung breast cancer guys thats sounds all very very good market cap easy 2Billions if lung Phase2 will be positiv than kabooom